Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas
Clinical trial NCT03920631 · WITHDRAWN
Trial details
- NCT number
- NCT03920631
- Sponsor
- Ahmed Galal, MD
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-10
- Primary completion
- 2023-03-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.